U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: April 17-23, 2022
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: April 17-23, 2022

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner of Food and Drugs

Event Date: 04/19/2022
Location: Virtual
Subject: Medical Device User Fee Act (MDUFA) V Public Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Open to the Public

Event Date: 04/20/2022
Location: Atlanta, GA
Subject: Prescription and Illicit Drug Summit; Plenary Speaker
FDA Participant/Group: ERICA JEFFERSON;
Non FDA Participant/Group: Medical professionals, law enforcement personnel, public health and prevention officials, federal, state and local officials and lawmakers, education specialists and researchers, treatment center owners and operators, first responders

Event Date: 04/21/2022
Location: Bethesda, MD
Subject: NIH Pragmatic Trials Collaboratory Steering Committee Meeting
FDA Participant/Group: DAYLE CRISTINZIO;
Non FDA Participant/Group: NIH representatives, coordinating center leadership, project clinicians, researchers, project managers

Event Date: 04/21/2022
Location: Virtual
Subject: University of Pittsburgh, Department of Epidemiology Spring 2022 Seminar
FDA Participant/Group: DAYLE CRISTINZIO;
Non FDA Participant/Group: University of Pittsburgh students, faculty, and staff

Official Name: Janet Woodcock, M.D., Principal Deputy Commissioner

Event Date: 04/20/2022
Location: Virtual
Subject: FY 2024 Budgetary Needs
FDA Participant/Group: BARRY DOWNING; JACQUELINE O SHAUGHNESSY; DAVID STRAUSS; RICHARD KEACH; TUCKER PATTERSON;
Non FDA Participant/Group: Senate congressional staff

Event Date: 04/20/2022
Location: Virtual
Subject: ACTIV-2/-3/-6 Trial Oversight Committee Meeting
FDA Participant/Group: PETER STEIN;
Non FDA Participant/Group: Parties involved in accelerating clinical trial development

Event Date: 04/20/2022
Location: Virtual
Subject: London Business School Conference: Sustaining Global Pharmaceutical Innovation and Access; Keynote Speech
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, and other stakeholders

Event Date: 04/21/2022
Location: Virtual
Subject: FY 2024 Budgetary Needs
FDA Participant/Group: TUCKER PATTERSON; JACQUELINE O SHAUGHNESSY; BARRY DOWNING; DAVID STRAUSS; RICHARD KEACH;
Non FDA Participant/Group: House congressional staff

Event Date: 04/21/2022
Location: Virtual
Subject: Patient Centered Outcome Research Institute (PCORI) Research Transformation Committee Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Committee members

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 04/20/2022
Location: Virtual
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: JOHN HASSENPLUG; LARRY MORRIS; CAITLIN BOON; DONALD PRATER;
Non FDA Participant/Group: Elliott Grant, Zara Khan (X Development LLC);

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Erica Jefferson, Associate Commissioner for External Affairs

No Significant Event

Official Name: Jacqueline O'Shaughnessy, Acting Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

No Significant Event

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 04/19/2022
Location: Virtual
Subject: Recall Updates
FDA Participant/Group: ARIEL SEELEY; LINDA RICCI; JAMES LEE; GINA BRACKETT; SHANIKA BOOTH; BRANDON BLAKELY; EITAN BERNSTEIN; MALVINA EYDELMAN; MICHAEL HOFFMANN; KAREN ARCHDEACON; MICHELLE TARVER; DENISE HAMPTON; RACHANA VISARIA; RACHAEL HUNT;
Non FDA Participant/Group: Andy Zeltwanger, David Ferguson, Francis Kim, Frans van Houten, Jan Bennik, Michele Buenafe, Roy Jakobs, Sylvia van Es, Tim Murphy, Tom Fallon, Tom Reimann (Philips);

Event Date: 04/20/2022
Location: Virtual
Subject: Medtronic Patient Safety and Quality Improvement Plan
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several Medtronic staff

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Michele Mital, Acting Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: Tucker Patterson, Ph.D., Acting Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event

 

Back to Top